Gene · 5350
Papers4,369
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 4,369
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| CD44 regulates Epac1-mediated β-adrenergic-receptor-induced Ca2+-handling abnormalities: implication in cardiac arrhythmias. | J Biomed Sci | 2023 | 37452346 | PubTator, text mining | PubMed |
| Successes and challenges of artificial intelligence in cardiology. | Front Digit Health | 2023 | 37448836 | PubTator, text mining | PubMed |
| Ribociclib Hybrid Lipid-Polymer Nanoparticle Preparation and Characterization for Cancer Treatment. | Polymers (Basel) | 2023 | 37447489 | PubTator, text mining | PubMed |
| Retrieval of HCV patients lost to follow-up as a strategy for Hepatitis C Microelimination: results of a Brazilian multicentre study. | BMC Infect Dis | 2023 | 37442976 | PubTator, text mining | PubMed |
| Hypothermic oxygenated perfusion attenuates DCD liver ischemia-reperfusion injury by activating the JAK2/STAT3/HAX1 pathway to regulate endoplasmic reticulum stress. | Cell Mol Biol Lett | 2023 | 37438690 | PubTator, text mining | PubMed |
| Ethnicity, consanguinity, and genetic architecture of hypertrophic cardiomyopathy. | Eur Heart J | 2023 | 37431535 | PubTator, text mining | PubMed |
| Fir(e)ing the Rhythm: Inflammatory Cytokines and Cardiac Arrhythmias. | JACC Basic Transl Sci | 2023 | 37426535 | PubTator, text mining | PubMed |
| Application of next generation sequencing in cardiology: current and future precision medicine implications. | Front Cardiovasc Med | 2023 | 37424920 | PubTator, text mining | PubMed |
| Evolving cardiovascular genetic counseling needs in the era of precision medicine. | Front Cardiovasc Med | 2023 | 37424912 | PubTator, text mining | PubMed |
| A Systematic Analysis of the Clinical Outcome Associated with Multiple Reclassified Desmosomal Gene Variants in Arrhythmogenic Right Ventricular Cardiomyopathy Patients. | J Cardiovasc Transl Res | 2023 | 37418234 | PubTator, text mining | PubMed |
| Characterization of Skeletal Muscle Biopsy and Derived Myoblasts in a Patient Carrying Arg14del Mutation in Phospholamban Gene. | Cells | 2023 | 37408239 | PubTator, text mining | PubMed |
| The pivotal role of ECG in cardiomyopathies. | Front Cardiovasc Med | 2023 | 37404739 | PubTator, text mining | PubMed |
| NNAT is a novel mediator of oxidative stress that suppresses ER + breast cancer. | Mol Med | 2023 | 37400769 | PubTator, text mining | PubMed |
| Bayesian estimation of gene constraint from an evolutionary model with gene features. | Res Sq | 2023 | 37398424 | PubTator, text mining | PubMed |
| A novel compound heterozygous variant in ALPK3 induced hypertrophic cardiomyopathy: a case report. | Front Cardiovasc Med | 2023 | 37396576 | PubTator, text mining | PubMed |
| Fluorescence lifetime FRET assay for live-cell high-throughput screening of the cardiac SERCA pump yields multiple classes of small-molecule allosteric modulators. | Sci Rep | 2023 | 37393380 | PubTator, text mining | PubMed |
| Overview of Cardiac Arrhythmias and Treatment Strategies. | Pharmaceuticals (Basel) | 2023 | 37375791 | PubTator, text mining | PubMed |
| Genetic Evaluation and Screening in Cardiomyopathies: Opportunities and Challenges for Personalized Medicine. | J Pers Med | 2023 | 37373876 | PubTator, text mining | PubMed |
| Omics Analyses of Stromal Cells from ACM Patients Reveal Alterations in Chromatin Organization and Mitochondrial Homeostasis. | Int J Mol Sci | 2023 | 37373166 | PubTator, text mining | PubMed |
The Junctophilin-2 Mutation p.(Thr161Lys) Is Associated with Hypertrophic Cardiomyopathy Using Patient-Specific iPS Cardiomyocytes and Demonstrates Prolonged Action Potential and Increased Arrhythmogenicity. | Biomedicines | 2023 | 37371654 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5350/papers?page=20